391 related articles for article (PubMed ID: 17222213)
1. The effects of glucocorticoid therapy on the inflammatory and dendritic cells in muscular dystrophies.
Hussein MR; Hamed SA; Mostafa MG; Abu-Dief EE; Kamel NF; Kandil MR
Int J Exp Pathol; 2006 Dec; 87(6):451-61. PubMed ID: 17222213
[TBL] [Abstract][Full Text] [Related]
2. Steroid therapy is associated with decreased numbers of dendritic cells and fibroblasts, and increased numbers of satellite cells, in the dystrophic skeletal muscle.
Hussein MR; Abu-Dief EE; Kamel NF; Mostafa MG
J Clin Pathol; 2010 Sep; 63(9):805-13. PubMed ID: 20819882
[TBL] [Abstract][Full Text] [Related]
3. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
Srivastava NK; Yadav R; Mukherjee S; Sinha N
Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
[TBL] [Abstract][Full Text] [Related]
4. Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies.
Hussein G; Mansour L; Ghafar HA; Mostafa FA; Fawaz L
J Investig Med; 2014 Aug; 62(6):875-9. PubMed ID: 24866459
[TBL] [Abstract][Full Text] [Related]
5. An Open Label Exploratory Clinical Trial Evaluating Safety and Tolerability of Once-Weekly Prednisone in Becker and Limb-Girdle Muscular Dystrophy.
Zelikovich AS; Joslin BC; Casey P; McNally EM; Ajroud-Driss S
J Neuromuscul Dis; 2022; 9(2):275-287. PubMed ID: 35124660
[TBL] [Abstract][Full Text] [Related]
6. Abnormal lipid metabolism in skeletal muscle tissue of patients with muscular dystrophy: In vitro, high-resolution NMR spectroscopy based observation in early phase of the disease.
Srivastava NK; Yadav R; Mukherjee S; Pal L; Sinha N
Magn Reson Imaging; 2017 May; 38():163-173. PubMed ID: 28069416
[TBL] [Abstract][Full Text] [Related]
7. Becker and Duchenne muscular dystrophy: a comparative morphological study.
Dennett X; Shield LK; Clingan LJ; Woolley DA
Aust Paediatr J; 1988; 24 Suppl 1():15-20. PubMed ID: 3202735
[TBL] [Abstract][Full Text] [Related]
8. Decorin and biglycan expression is differentially altered in several muscular dystrophies.
Zanotti S; Negri T; Cappelletti C; Bernasconi P; Canioni E; Di Blasi C; Pegoraro E; Angelini C; Ciscato P; Prelle A; Mantegazza R; Morandi L; Mora M
Brain; 2005 Nov; 128(Pt 11):2546-55. PubMed ID: 16183658
[TBL] [Abstract][Full Text] [Related]
9. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
Niebrój-Dobosz I; Fidziańska A; Glinka Z; Hausmanowa-Petrusewicz I
Folia Neuropathol; 2002; 40(3):143-50. PubMed ID: 12572920
[TBL] [Abstract][Full Text] [Related]
10. CD4+ cells, macrophages, MHC-I and C5b-9 involve the pathogenesis of dysferlinopathy.
Yin X; Wang Q; Chen T; Niu J; Ban R; Liu J; Mao Y; Pu C
Int J Clin Exp Pathol; 2015; 8(3):3069-75. PubMed ID: 26045819
[TBL] [Abstract][Full Text] [Related]
11. Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions.
Politano L; Scutifero M; Patalano M; Sagliocchi A; Zaccaro A; Civati F; Brighina E; Vita G; Messina S; Sframeli M; Lombardo ME; Scalise R; Colia G; Catteruccia M; Berardinelli A; Motta MC; Gaiani A; Semplicini C; Bello L; Astrea G; Ricci G; D'Angelo MG; Vita G; Pane M; D'Amico A; Balottin U; Angelini C; Battini R; Magliano L
Acta Myol; 2017 Mar; 36(1):19-24. PubMed ID: 28690390
[TBL] [Abstract][Full Text] [Related]
12. Intermittent Glucocorticoid Dosing Improves Muscle Repair and Function in Mice with Limb-Girdle Muscular Dystrophy.
Quattrocelli M; Salamone IM; Page PG; Warner JL; Demonbreun AR; McNally EM
Am J Pathol; 2017 Nov; 187(11):2520-2535. PubMed ID: 28823869
[TBL] [Abstract][Full Text] [Related]
13. Patterns of cardiac involvement in different muscular dystrophies assessed by magnetic resonance imaging.
Goebel J; Schult K; Schara U; Neudorf U; Forsting M; Schlosser T; Nassenstein K
Acta Radiol; 2023 Feb; 64(2):605-611. PubMed ID: 35147046
[TBL] [Abstract][Full Text] [Related]
14. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
Voit T; Stuettgen P; Cremer M; Goebel HH
Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
[TBL] [Abstract][Full Text] [Related]
15. Autopsy analyses of the muscular dystrophies.
Moriuchi T; Kagawa N; Mukoyama M; Hizawa K
Tokushima J Exp Med; 1993 Jun; 40(1-2):83-93. PubMed ID: 8211986
[TBL] [Abstract][Full Text] [Related]
16. Corticosteroid therapy in Duchenne muscular dystrophy.
Khan MA
J Neurol Sci; 1993 Dec; 120(1):8-14. PubMed ID: 8289083
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and new treatments in muscular dystrophies.
Manzur AY; Muntoni F
J Neurol Neurosurg Psychiatry; 2009 Jul; 80(7):706-14. PubMed ID: 19531685
[TBL] [Abstract][Full Text] [Related]
19. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
[TBL] [Abstract][Full Text] [Related]
20. Dystrophin and nebulin in the muscular dystrophies.
Patel K; Voit T; Dunn MJ; Strong PN; Dubowitz V
J Neurol Sci; 1988 Nov; 87(2-3):315-26. PubMed ID: 3062133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
